09 November 2021

PSILOCYBIN: Business Magic Solutions for Depression Therapies

Business

Magic Mushroom-Based Therapy for Depression Shows Promise

A mock patient in trial site therapy room.
A mock patient in trial site therapy room. Source: Compass Pathways Plc
By  and 
November 9, 2021, 5:00 AM MST Updated on November 9, 2021, 5:24 AM MST
  •  
    Effects seen day after taking mushroom-like drug, CEO says
  •  
    Some patients showed suicidal and self-harming behaviors

Compass Pathways Plc’s experimental therapy based on psilocybin, or so-called magic mushrooms, showed promise in a midstage clinical trial in patients whose depression didn’t improve from other treatments. 

Nearly a quarter of the people treated with the highest dose of Compass Pathways’ drug candidate, called COMP360, saw the severity of their depression reduced after three months, as measured on a scale used by psychiatrists. COMP360 is a patented formulation of the active ingredient in psychedelic mushrooms.

No comments:

Iran Focuses on Modern Submarines in Major Naval Expansion.

Iran Focuses on Modern Submarines in Major Naval Expansion. 25 Nov, 2024 - 12:11 Naval News Navy 2024 According to information published by ...